SSY Group 2005.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

2.70

+3.05%

Close of 10 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in HKD, from our data supplier.

FY2025

Revenue

HK$4.17bn

FY2016FY2025

Net income

HK$470.6m

FY2016FY2025

Free cash flow

HK$299.8m

FY2016FY2025

Shareholders' equity

HK$7.30bn

FY2016FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	HK$4.17bn	HK$5.77bn	HK$6.46bn	HK$6.43bn	HK$5.36bn	HK$4.26bn	HK$4.64bn	HK$4.18bn	HK$3.08bn	HK$2.36bn
Gross profit	HK$1.73bn	HK$2.91bn	HK$3.62bn	HK$3.44bn	HK$3.04bn	HK$2.58bn	HK$2.79bn	HK$2.61bn	HK$1.81bn	HK$1.22bn
Research and development	HK$244.0m	HK$266.0m	HK$289.7m	HK$259.1m	HK$248.0m	HK$126.9m	HK$75.4m	HK$46.8m	HK$58.1m	HK$41.4m
Operating income	HK$628.9m	HK$1.34bn	HK$1.64bn	HK$1.42bn	HK$988.1m	HK$758.9m	HK$1.42bn	HK$1.11bn	HK$853.0m	HK$666.6m
Net income	HK$470.6m	HK$1.06bn	HK$1.32bn	HK$1.12bn	HK$785.5m	HK$612.0m	HK$1.14bn	HK$911.8m	HK$664.7m	HK$489.5m
Diluted earnings per share	0.16	0.36	0.44	0.38	0.26	0.20	0.37	0.30	0.23	0.17

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Total assets	HK$12.81bn	HK$12.60bn	HK$11.97bn	HK$10.97bn	HK$10.71bn	HK$9.25bn	HK$7.72bn	HK$6.88bn	HK$5.90bn	HK$4.74bn
Cash and short-term investments	HK$1.82bn	HK$1.29bn	HK$1.62bn	HK$1.71bn	HK$1.70bn	HK$1.45bn	HK$824.7m	HK$984.3m	HK$741.2m	HK$454.6m
Total liabilities	HK$5.19bn	HK$5.07bn	HK$4.70bn	HK$4.42bn	HK$4.22bn	HK$3.34bn	HK$2.48bn	HK$2.50bn	HK$2.42bn	HK$2.06bn
Debt	HK$4.02bn	HK$3.64bn	HK$3.37bn	HK$3.21bn	HK$3.11bn	HK$2.44bn	HK$1.70bn	HK$1.49bn	HK$1.75bn	HK$1.57bn
Shareholders' equity	HK$7.30bn	HK$7.22bn	HK$6.93bn	HK$6.21bn	HK$6.22bn	HK$5.65bn	HK$4.99bn	HK$4.24bn	HK$3.48bn	HK$2.68bn
Shares outstanding	2,918m	2,958m	2,974m	2,980m	3,020m	3,044m	3,052m	3,047m	2,942m	2,869m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash from operations	HK$635.0m	HK$491.0m	HK$925.7m	HK$733.7m	HK$747.9m	HK$527.6m	HK$669.4m	HK$969.8m	HK$552.4m	HK$686.5m
Capital spending	−HK$335.3m	−HK$540.4m	−HK$703.9m	−HK$418.1m	−HK$388.3m	−HK$291.0m	−HK$816.3m	−HK$533.1m	−HK$231.2m	−HK$279.4m
Free cash flow	HK$299.8m	−HK$49.4m	HK$221.9m	HK$315.6m	HK$359.6m	HK$236.6m	−HK$147.0m	HK$436.8m	HK$321.3m	HK$407.1m
Dividends paid	−HK$427.1m	−HK$534.1m	−HK$445.5m	−HK$388.1m	−HK$302.6m	−HK$332.9m	−HK$302.4m	−HK$241.1m	−HK$170.7m	−HK$71.1m

Latest quarters

By quarter end

	Jun 2026	Dec 2025	Jun 2025	Dec 2024	Jun 2024	Dec 2023	Jun 2023	Dec 2022
Revenue	HK$2.36bn	HK$2.02bn	HK$2.15bn	HK$2.43bn	HK$3.34bn	HK$3.13bn	HK$3.33bn	HK$3.03bn
Gross profit	HK$912.1m	HK$840.7m	HK$890.4m	HK$1.06bn	HK$1.84bn	HK$1.60bn	HK$1.89bn	HK$1.57bn
Operating income	HK$389.5m	HK$258.1m	HK$370.9m	HK$494.2m	HK$849.3m	HK$743.0m	HK$747.2m	HK$630.9m
Net income	HK$320.3m	HK$187.1m	HK$283.5m	HK$375.4m	HK$685.7m	HK$680.0m	HK$638.6m	HK$552.8m
Diluted earnings per share	0.11	0.06	0.10	0.13	0.23	0.23	0.21	0.19
Cash from operations	—	HK$442.0m	HK$194.0m	HK$217.0m	HK$349.0m	HK$473.0m	HK$492.0m	HK$578.0m
Capital spending	—	−HK$59.0m	−HK$134.0m	−HK$152.0m	−HK$178.0m	−HK$240.0m	−HK$323.0m	−HK$181.0m
Free cash flow	—	HK$383.0m	HK$60.0m	HK$65.0m	HK$171.0m	HK$233.0m	HK$169.0m	HK$397.0m
Total assets	HK$13.47bn	HK$12.81bn	HK$12.79bn	HK$12.60bn	HK$12.55bn	HK$11.97bn	HK$11.33bn	HK$10.97bn
Cash and short-term investments	HK$1.97bn	HK$1.82bn	HK$1.52bn	HK$1.29bn	HK$1.61bn	HK$1.62bn	HK$1.87bn	HK$1.76bn
Debt	HK$1.86bn	HK$4.02bn	HK$4.02bn	HK$3.64bn	HK$3.61bn	HK$3.37bn	HK$3.39bn	HK$3.21bn
Shareholders' equity	HK$7.80bn	HK$7.30bn	HK$7.27bn	HK$7.22bn	HK$7.25bn	HK$6.93bn	HK$6.35bn	HK$6.21bn

Financial ratios

Data as of 7 Oct 2026

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Gross margin	41.6%	50.4%	56.0%	53.5%	56.7%	60.6%
Operating margin	14.3%	23.3%	26.4%	23.1%	18.8%	18.2%
Net margin	11.3%	18.4%	20.4%	17.5%	14.7%	14.4%
Return on equity	6.4%	14.7%	19.0%	18.1%	12.6%	10.8%
Return on assets	3.7%	8.4%	11.0%	10.2%	7.3%	6.6%
Free cash flow yield	12.1%	12.7%	20.0%	14.1%	13.7%	9.8%
Revenue growth	-27.8%	-10.7%	0.5%	20.1%	25.7%	-8.1%
Earnings growth	-55.6%	-19.5%	17.4%	42.9%	28.4%	-46.1%
Current ratio	1.89x	2.78x	2.03x	1.82x	2.04x	2.01x
Debt to equity	0.55x	0.50x	0.49x	0.52x	0.50x	0.43x
Equity ratio	57.0%	57.3%	57.9%	56.7%	58.1%	61.1%
Interest coverage	5.64x	10.59x	13.63x	16.85x	16.47x	15.09x
R&D as a share of sales	5.9%	4.6%	4.5%	4.0%	4.6%	3.0%
Buybacks as a share of market value	1.3%	0.5%	0.2%	1.3%	0.8%	0.3%

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	-13.5%	-0.5%	6.5%
Operating income	-23.8%	-3.7%	1.5%
Net income	-25.2%	-5.1%	1.6%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Gross margin	46.7%	51.2%	53.4%	54.8%
Operating margin	19.8%	22.0%	20.9%	23.2%
Net margin	15.4%	17.4%	16.5%	18.3%

Valuation history

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Price to earnings	17.6	9.9	11.1	11.4	15.4	21.9	16.9	19.4	21.3	14.5
Price to sales	2.0	1.8	2.3	2.0	2.3	3.1	4.2	4.2	4.6	3.0

Dividends and splits

Per share, in the currency the company pays

Paid for 20 years. Last went ex-dividend on 20 May 2026.

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019
Paid in the year	0.03	0.145	0.19	0.15	0.13	0.10	0.11	0.10

6-for-5 split · 24 Sept 2012
5-for-1 split · 29 Aug 2007

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

SSY Group 2005.HK · HKD

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Financial ratios

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology